Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis

Clinical trial NCT05802056 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05802056
Sponsor: Mayo Clinic
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical Stage IV Gastric Cancer AJCC v8 Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Metastatic Gastric Carcinoma Metastatic Malignant Neoplasm in the Peritoneum

Start date: 2023-11-29
Primary completion: 2027-04-24
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.